The future looks very bullish for this vaccine specialist. At the beginning of 2020, Novavax (NASDAQ:NVAX) had a valuation of $4 a share. Six months later, the company's stock sells for $47 a share. That's a dramatic shift in perception of value. What's the stock market seeing now that it didn't see in January? In a…
Novavax is well ahead in clinical testing than two of the White House's COVID-19 vaccine finalists. No company has developed a COVID-19 vaccine that's been proven to be safe and effective yet. But several appear to be getting a big boost for their efforts from Uncle Sam. The New York Times reported on Wednesday that…
(Oona Zenda/KFF Health News) As Grace Griffin and her husband were welcoming their long-awaited baby — a daughter — Griffin found herself worried about looming medical bills and unsure if their family could pay for the care they needed. “This whole experience has me wondering (keeping me up at night, actually): Can we ever afford
LYON, France — Halving the dose of antenatal betamethasone given to prevent severe respiratory distress syndrome (RDS) in infants does not appear to affect later intelligence quotient (IQ) scores or other measures of neurodevelopment, suggests a follow-up study of a randomized trial. However, it is unclear from the present data, presented at the Congress of
After years of searching for affordable health insurance, Trey Wright discovered Georgia Pathways to Coverage. The state’s limited Medicaid expansion program allowed the 27-year-old living in the rural city of Jesup in southeastern Georgia to finally visit a primary care doctor regularly. It also covered weekly shots to manage an array of allergies, saving him